Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention

The Prostate Cancer Prevention Trial (PCPT) demonstrated a risk of prostate cancer at prostate-specific antigen (PSA) < 4.0 ng/ml and that prostate cancer risk is reduced by finasteride. A major concern about early detection by PSA and prevention by finasteride is that they may involve biological...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Lucia, M. Scott, Darke, Amy K., Goodman, Phyllis J., Tangen, Catherine M., Rosa, Francisco G. La, Parnes, Howard L., Ford, Leslie G., Coltman, Charles A., Thompson, Ian M.
格式: Artigo
語言:Inglês
出版: 2008
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3985428/
https://ncbi.nlm.nih.gov/pubmed/19138952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-08-0078
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍